CELLS encounter environmental stress on a continual basis and have evolved mechanisms to monitor the integrity of the genome and prevent temporary DNA lesions from becoming permanent DNA mutations. A central factor in genome monitoring is the protein complex Replication Protein A (RPA). The canonical RPA complex is composed of three subunits named [RPA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065), [RPA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256), and [RPA3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003709), also often referred to by their apparent molecular weights as [RPA70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065), [RPA32](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256), and [RPA14](http://www.yeastgenome.org/locus/S000003709/overview), respectively ([@bib84]; [@bib38]; [@bib23]; [@bib88]; [@bib56]). Originally identified as a protein complex essential for *in vitro* SV40 DNA replication ([@bib85]; [@bib86]; [@bib82]), this complex is also essential for DNA repair/recombination ([@bib50]; [@bib25]; [@bib77]; [@bib78]) and has roles in cell-cycle regulation ([@bib51]; [@bib44]; [@bib4]; [@bib2]). This is consistent with the major biochemical function of RPA, which is high-affinity binding to single-strand DNA (ssDNA), an intermediate of replication, repair/recombination, and substrate for checkpoint activation ([@bib73]; [@bib26]; [@bib55]; [@bib5]).

In addition to acting as a "sensor" of DNA damage through its ability to bind to ssDNA, RPA is also post-translationally modified in response to DNA damage. Identified post-translational modifications of RPA include acetylation ([@bib14]), sumoylation ([@bib13]; [@bib21]), and phosphorylation ([@bib20]; [@bib22]; [@bib47], [@bib48], [@bib49]; [@bib36]; [@bib11]; [@bib10]; [@bib40]; [@bib79]; [@bib59]; [@bib3], [@bib4]; [@bib43]; [@bib70]; [@bib81]). Most studies of RPA post-translational modifications have focused on hyperphosphorylation of the 40-amino-acid (aa) N-terminal region of human RPA2 in response to DNA damage. The use of "extensive" phospho-mutants (*i.e.*, those in which all serines/threonines in the region are changed to aspartic acids to mimic phosphorylation or alanines to prevent phosphorylation) indicates that mimicking a hyperphosphorylated state results in the inability to detect RPA2 foci at replication centers in otherwise unstressed human cells ([@bib79]). This suggests that in response to DNA damage, phosphorylated human RPA is recruited away from replication centers to perform functions in DNA repair. Mutagenesis studies have also indicated that phosphorylation of the human RPA2 N-terminus (NT) is important for halting the cell cycle during replicative stress ([@bib59]), for progression into mitosis ([@bib57]; [@bib4]; [@bib2]), and for differential protein interactions with some DNA-damage response proteins ([@bib57], [@bib58]; [@bib60]; [@bib87]).

Within the human RPA2 NT are nine serine/threonine (S/T) residues that are targets for phosphorylation ([@bib38]; [@bib3]; [@bib49]). The combination of various RPA2 phospho-mutants and the generation of phospho-specific human RPA2 antibodies have advanced this area of research by allowing for the examination of phosphorylation at each individual target residue. The sites in the human RPA2 NT appear to be differentially phosphorylated in response to various types of DNA damage ([@bib49]), likely due to different checkpoint kinases (*e.g.*, ATR, ATM, and DNA-PK) having different preferential targets within the RPA2 NT ([@bib11]; [@bib59]; [@bib19]; [@bib80]; [@bib46]; [@bib49]). Also, sequential phosphorylation of the human RPA2 NT has been reported, indicating a dependence on phosphorylation of one site to promote phosphorylation of another ([@bib3]; [@bib49]). Although it is clear that many sites are differentially phosphorylated, the mechanism(s) by which post-translational modification of each site contributes to human RPA function in response to DNA damage remains undefined.

Recent examination of phosphorylation of Replication Factor A (RFA; yeast RPA) in the pathogenic yeast *Candida albicans* demonstrated that [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) phosphorylation occurs both during the cell cycle and in response to DNA damage ([@bib81]; [@bib29]), similar to findings in *Saccharomyces cerevisiae* ([@bib20]; [@bib11]; [@bib6]). Dephosphorylation of *C. albicans* [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) requires the [Pph3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002482)--[Psy2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005145) phosphatase complex ([@bib81]; [@bib29]), and the PP2AC and PP4C phosphatases are necessary to dephosphorylate human RPA2 during the DNA-damage response ([@bib24]; [@bib43]). Mass spectrometry analysis of proteins isolated from unstressed *C. albicans [pph3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002482)*Δ mutant cells revealed five potential targets of phosphorylation in [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256), none of which were located within the first 40 amino acids. Upon treatment of *Candida* cells with hydroxyurea (HU), it was determined that T11, S18, S29, and S30 in the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT are targets of phosphorylation by the yeast checkpoint kinase and ATR homolog, [Mec1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000340) ([@bib81]; [@bib29]).

In the budding yeast *S. cerevisiae*, post-translational modifications of Replication Factor A have been observed in response to DNA damage. Similar to human RPA1, yeast [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) and [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) are sumoylated in response to treatment of cells with methyl methanesulfonate (MMS) ([@bib13]; [@bib18]; [@bib64]). Phosphorylation of yeast [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) at serine 178 (S178) and [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) at serine 122 (S122) by [Mec1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000340) has also been observed in response to chemically induced DNA damage during mitosis ([@bib11], [@bib12]; [@bib10]; [@bib6]). Furthermore, [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--S122 is phosphorylated in response to programmed double-strand break (DSB) formation during meiosis ([@bib12]; [@bib7]). Yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) can also be phosphorylated at serine 27 (S27) by the meiosis-specific kinase [Ime2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003642) ([@bib15], [@bib16]), and it has been suggested that other unidentified residues in the N-terminus are also post-translationally modified during meiosis ([@bib15]). Rad53-dependent phosphorylation of the *Saccharomyces* [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT has been observed in mitotically growing cells; however, this phosphorylation is observed only in a *[set1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001161)*Δ mutant. Global mass-spectrometry analyses thus far have confirmed phosphorylation of [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)--S178 and [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--S122 and have revealed other phosphorylation target sites ([Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)--S160; [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--T38, S115, S116, Y120, S189; [Rfa3](http://www.yeastgenome.org/locus/S000003709/overview)--S34; <http://www.phosphogrid.org>; [@bib74]; [@bib1]; [@bib37]; [@bib30]; [@bib35]; [@bib76]; [@bib75]), although the biological significance of each has yet to be determined.

In this study, the function of the *Saccharomyces* [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT in the DNA-damage response was examined through a detailed genetic analysis of this region. It was determined that the *Saccharomyces* [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is necessary, yet its phosphorylation is not required for a proper DNA-damage response. Although phosphorylation is not required, a constitutive phospho-mimetic form of [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) resulted in sensitivity to DNA damage. Genetic interaction analyses indicate that the basis for this sensitivity is different from the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) mutant lacking this domain. Utilizing multiple mutant forms of yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256), specific subregions of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT important for the damage response were identified. Finally, although [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) phospho-mutants do not obviously affect initiation of checkpoint function, the phospho-mimetic form of [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) displayed genetic interactions and a checkpoint adaptation phenotype (*i.e.*, release from the G2/M checkpoint in the presence of unrepaired DNA damage) similar to that observed for *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* mutant cells.

Materials and Methods {#s1}
=====================

Strains and plasmids {#s2}
--------------------

Yeast strains and plasmids used in this study are described in [Supporting Information](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-1.pdf), [Table S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-8.pdf), and [Table S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-5.pdf), respectively. The yeast strains RMY122-A (*MATa [leu2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000523)-3,112 [trp1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002414)-1 [can1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000789)-100 [ura3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000747)-1 [his3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005728)-11,15 [rad5](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004022)--G535R [rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)*Δ::*[TRP1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002414)[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*Δ::*[TRP1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002414)*) and RMY122--*[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ were used to measure viability after plasmid shuffle and after DNA-damage treatment and are derivatives of W303 ([@bib54]; kindly provided by Steve Brill). These strains also contain a centromeric vector, pJM132 (pRS416 derivative), which includes the wild-type *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)*, *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*, and *[RFA3](http://www.yeastgenome.org/locus/S000003709/overview)* genes expressed from their native promoters. All strains used for adaptation studies are derivatives of JKM179 ([@bib44]; kindly provided by Jim Haber).

To generate a yeast shuttle vector containing wild-type *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* and its native promoter, pJM132 was digested with *Bam*HI and *Hin*dIII, and this 2.6-kbp fragment was cloned into pRS313 ([@bib71]) to generate pRS313--*[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)*. The vector pKU2--*[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* ([@bib78]), containing the *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* (K45E) mutation, was digested with *Age*I and *Hin*dIII, and this 2.0-kbp fragment was cloned into pRS313--*[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* to generate pRS313--*[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11*.

A yeast shuttle vector containing wild-type *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* and its native promoter was generated as follows. *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* cDNA was removed from pGDB-C3--*[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* by cleaving with *Eco*RI and *Hin*dIII (partial digest), and this 0.9-kbp fragment was cloned into the low-copy centromeric vector pRS315 ([@bib71]) to generate pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δpromoter (note that this plasmid contains a serine instead of a threonine at residue 3 of [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)). To amplify the native *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* promoter, PCR was performed on pJM218 ([@bib54]) using primers --PR-R1 and --PR--*Nco*I. The resulting fragment was digested with *Sac*II and *Nco*I and cloned into pRS315--*[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δpromoter to generate pRS315--*[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*.

N-terminal phospho-mutant forms of the *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* gene were generated as follows. The plasmid pGDB-C3--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* was constructed by annealing five overlapping complementary primers (AspA-E; [Table S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-4.pdf)), followed by insertion of this fragment into pGDB-C3--*[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* partially digested with *Eco*RI--*Hpa*I. The partially digested 0.9-kbp *Eco*RI--*Hin*dIII fragment from pGDB-C3--*[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* was then cloned into pRS315 to generate pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~*-Δpromoter. The native *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* promoter was amplified as described previously, digested with *Sac*II and *Nco*I, and cloned into pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~*-Δpromoter to generate pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~*. To generate pGDB-C3--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~*, five overlapping complementary primers (AlaA-E; [Table S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-4.pdf)) were annealed followed by insertion into the *Nco*I and *Hpa*I sites of pGDB-C3--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~*. Again, the 0.9-kbp *Eco*RI--*Hin*dIII fragment produced by partial digestion of this plasmid was cloned into pRS315 to produce pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~*-Δpromoter. The PCR fragment containing the native *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* promoter was digested with *Bam*HI and *Nco*I and inserted into pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~*-Δpromoter to generate pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~*. Deletion of the N-terminus of *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* was achieved by PCR amplification of *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* cDNA from pJM218 with a primer in which the codon for amino acid 39 was replaced with a start codon contained within an *Nco*I site. The resulting PCR product was digested with *Nco*I and *Hin*dIII and ligated into pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* to generate pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~*.

Yeast integrating plasmids were also generated for each of the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* N-terminal mutant forms. Briefly, the 1.2-kbp *Bam*HI--*Hin*dIII fragment from pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* and pRS315--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* were each cloned into pRS306 to generate pRS306--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* and pRS306--*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~*, respectively. These plasmids were then digested with *Eco*RI to target integration into JKM179, and two-step gene replacement was performed to generate *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* or *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant strains. Double-mutant derivatives of JKM179 were generated by crossing isogenic strains, followed by sporulation and microdissection.

The construction of all individual and multimutant plasmids was performed using pAW7 as the original DNA template. Briefly, *in vitro* site-directed mutagenesis using *Phusion* DNA Polymerase (New England BioLabs) and the corresponding mutagenic primer listed in [Table S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-4.pdf) were performed. Following *Dpn*I digestion, the mutagenesis reaction was transformed into bacterial cells. Plasmid DNA was isolated from resulting colonies and each mutation was verified by restriction digestion and sequencing.

Assessing the viability and recovery of *rfa2* N-terminal mutants by plasmid shuffle {#s3}
------------------------------------------------------------------------------------

Centromeric plasmids containing various forms of *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* (pRS313 derivative; *[HIS3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005728)*) and *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* (pRS315 derivative; *[LEU2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000523)*) were cotransformed into RMY122-A or RMY122--*[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ cells. Transformants were selected on synthetic complete (0.5% ammonium sulfate, 0.17% yeast nitrogen base without amino acids) media containing 2% dextrose and lacking histidine, leucine, and uracil (SD--His--Leu--Ura), resulting in cells that contained three plasmids. Cells were grown in media (SD--His--Leu) selecting for the cotransformed vectors containing *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* and *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* alleles. If the allelic forms of *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* or *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* support growth, the pJM132 vector can be lost, and these cells can be recovered on media containing 0.8 μg/ml 5-fluoroorotic acid (5-FOA). If the allelic forms of *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* and/or *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* cannot support growth, no 5-FOA-resistant cells can be recovered. Finally, if there were synthetic growth defects due to the allelic forms of *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* and/or *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*, reduced loss of pJM132 (and a reduced number of 5-FOA-resistant cells) or slower growth of colonies on 5-FOA media is observed.

To assess the viability of *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* and/or *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* allele mutants, cells containing all three plasmids were grown in SD--His--Leu media overnight (16--24 hr) at 30° at 220 rpm. The next day, cells were counted and diluted to an initial concentration of 1 × 10^6^ cells/ml. Tenfold serial dilutions were made, and 5 μl of cells from the initial concentration and serial dilutions were spotted onto SD--His--Leu and 5-FOA plates, and 50 μl of the initial dilution were also spread onto 5-FOA plates. Growth was compared on the 5-FOA plates and quantitated. From the 5-FOA spread plates, we recovered mutant strains that were used in further studies.

Measuring growth rates of mutant strains {#s4}
----------------------------------------

Yeast cells were grown overnight at 30° in 25--50 ml YPD (1% yeast extract, 2% peptone, 2% dextrose). The absorbance at 600 nm was measured to ensure that cells were in exponential phase (OD~600~ \< 2). Cells were then diluted to OD~600~ = 0.1 in 50 ml YPD, measured to verify the initial concentration (OD~600~), and grown at 30°. After 6--8 hr, the final concentration (OD~600~) was measured. Growth rate (*g*; minutes per generation) was then calculated using the equation$$\mathit{g} = {\mathit{t}/\left\lbrack {{\text{ln}\left( {\mathit{C}_{\text{f}}/\mathit{C}_{\text{i}}} \right)}/{\text{ln}\left( 2 \right)}} \right\rbrack},$$where *t* is the time of growth, *C*~f~ is the final concentration of cells, and *C*~i~ is the initial concentration of cells. Measurements were taken for at least three independent cultures.

DNA-damage spot assays {#s5}
----------------------

Mutant strains that were viable were recovered as described above. These mutant strains were subjected to DNA-damaging agents as follows. Wild-type or mutant cells were grown in liquid YPD overnight (16--24 hr) at 30° at 220 rpm. The next day, cell concentrations were determined, and an initial dilution of cells to 2.4 × 10^5^ cells/ml was made. Threefold serial dilutions were performed, and 5 μl from the initial dilution and serial dilutions were spotted onto the following plates: YPD, YPD + 0.012--0.03% MMS, YPD + 0.2--25 μg/ml camptothecin (CPT), YPD + 40--360 mM HU, YPD + 0.2--25 μg/ml phleomycin (PHL), and SD--His--Leu. Plates were incubated for 2--4 days at 30°, and growth differences between the mutant and wild-type cells were documented.

Immunoblotting {#s6}
--------------

For protein analysis, wild-type and mutant cells were grown in liquid YPD media overnight (12--16 hr) to a concentration of ∼1 × 10^7^ cells/mL. The next day, cells were subcultured into fresh media to a concentration of ∼2.5 × 10^6^ cells/ml and grown for two generations. The cell cultures were split into two cultures, and MMS was added to one of the cultures to a final concentration of 0.03%. The cultures with/without MMS were grown at 30° for an additional 3 hr. For protein extraction, ∼3 × 10^7^ cells were collected and treated as described by [@bib42]. The samples were incubated at 100° for 3 min and centrifuged at 21,000 × *g* for 1 min, and the indicated amounts of the supernatant were loaded onto SDS--PAGE gels (described below).

To detect [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) activation (*i.e.*, phosphorylation), we loaded 10 μl (out of 100 μl) of sample onto a 6% SDS--polyacrylamide (37.5:1 mono:bis) mini gel. Following electrophoresis and transfer to 0.4-μm nitrocellulose, the blot was blocked with 10% skim milk in TBS-T for 1--2 hr, followed by primary antibody incubation with rabbit polyclonal anti-Rad53 (Abcam) at a 1:6,000 dilution in 10% skim milk for 16--20 hr. After multiple washes with TBS-T, the blot was incubated with goat anti-rabbit IgG-HRP secondary antibody (Abcam) at a 1:40,000 dilution in 10% skim milk for 2 hr. The blot was washed multiple times and developed using the ECL2 Western Blotting Substrate (Thermo Scientific). Signal on the blot was detected using either myECL Imager (Thermo Scientific) or a Storm 865 (GE Healthcare).

To detect [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256), and its post-translational modification, 10 μl of extract was loaded onto a 8% polyacrylamide (29:1 mono:bis) gel with or without 25--50 μM Phos-Tag ([@bib41]). The gel was transferred, and the blot was blocked as previously described. The blot was incubated with rabbit polyclonal anti-[Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) (kindly provided by Steve Brill) at a 1:20,000 dilution in 10% skim milk for 16--20 hr. Secondary antibody incubation, washes, and developing of the blot were as described previously for [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074). Detection of [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065), and its post-translational modification, was as described for [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256), except that 0.5 μl (out of 100 μl) protein extract was used, and the primary antibody used was rabbit anti-Rfa1 (kindly provided by Steve Brill) at a 1:40,000 dilution in 10% skim milk for 16--20 hr. All secondary antibody incubations, washes, and developing of the blot were as described for [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074).

Measuring checkpoint adaptation {#s7}
-------------------------------

The yeast strain JKM179, containing a deletion of both *[HML](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000029214)* and *[HMR](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000029655)*, was used to measure the ability of cells to override G2/M arrest in the presence of DNA damage (*i.e.*, adaptation) as described previously ([@bib44]). Two-step gene replacement was used to introduce allelic forms of *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* and/or *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*, as described in the strains and plasmids section. The cells were grown overnight in YPR (1% yeast extract, 2% peptone, 2% raffinose) media and single unbudded G1 cells were microdissected onto synthetic complete plates containing 2% galactose and all required amino acids (SG--Com). At 0, 8, and 24 hr, each dissected cell was examined for progression through the cell cycle as evidenced by the appearance of multiple cells (*i.e.*, cell division). Additionally, *[RFA1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)* and *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* mutant alleles were combined with other gene deletion mutations (*i.e.*, *[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ) and examined for cell division.

To measure [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) phosphorylation, JKM179 derivatives were grown overnight in YPD to exponential phase. These cells were then transferred to YPR and grown 12--16 hr to exponential phase (∼1 × 10^7^ cells/ml). Galactose was added to a final concentration of 2% to induce [HO](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000002386) endonuclease expression, and cells were collected at various times after galactose addition. Protein was isolated using the method of [@bib62]. Forty micrograms of each protein sample was separated on a 7.5% (37.5:1) SDS--polyacrylamide gel, and [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) immunoblotting was performed as described above.

Results {#s8}
=======

Yeast RFA double mutants lacking both characterized Mec1 target sites do not display sensitivity to DNA-damaging agents {#s9}
-----------------------------------------------------------------------------------------------------------------------

The two major *Saccharomyces* RFA phosphorylation target sites ([Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)--S178 and [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--S122) lie in the [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) linker region just upstream of DNA binding domain A (DBD-A) and in the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) loop 3--4 region ([@bib11]; [@bib10]; [Figure 1A](#fig1){ref-type="fig"}). Upon DNA damage, both sites (which are present as SQ motifs) are phosphorylated by the checkpoint kinase [Mec1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000340). Previous studies reported no obvious DNA-damage sensitivity when either site was mutated individually ([@bib11]; [@bib10]; [@bib53]), and in meiosis, the only detectable effect is on crossover *vs.* noncrossover frequency when [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--S122 was mutated ([@bib7]). Potential redundancy of these two [Mec1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000340) target sites had not been examined.

![DNA-damage assay of known phosphorylation site mutants. (A) Schematic of RFA complex and individual subunits. The DNA-binding domains (DBDs) of the RFA subunits are shown (F, A, B, and C in *Rfa1*; D in *Rfa2*; E in *Rfa3*), along with linker regions (designated by thick lines connecting DBDs and other regions), the putative C-terminal winged-helix domain (W) of Rfa2, and the putative N-terminal phosphorylation domain (P) of Rfa2. Mec1 damage-dependent target sites are denoted by a lightning symbol, with the target residue (*e.g.*, S) and residue number (*e.g.*, 178) denoted. (B) DNA-damage assays of *rfa2-S122* and *rfa1-S178* mutants. Alanine, A, or aspartic acid, D, mutant forms were examined in this study. Cells were grown overnight, sonicated, counted, and diluted to 2.4 × 10^5^ cells/ml. Threefold serial dilutions were made, and 5 μl of each dilution were spotted onto YPD (unstressed) or YPD containing 80 mM hydroxyurea (HU), 0.024% methyl methanesulfonate (MMS), or 1 μg/ml camptothecin (CPT). Plates were incubated for 2--4 days at 30°. The *rfa1-t11* strain was used as a control for DNA-damage sensitivity. (C) DNA-damage assays of *rfa2-S122* and *rfa1-S178* double mutants. Damage assays were performed as described in [Figure 1B](#fig1){ref-type="fig"}.](711fig1){#fig1}

Using a genetic approach, aspartic acid (*i.e.*, phospho-mimetic) or alanine (*i.e.*, nonphosphorylatable) forms of yeast [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)--S178 and [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--S122 were generated. All possible mutant combinations were recovered by plasmid shuffle, indicating that mutation of either or both sites does not affect cell viability. When exposed to the DNA-damaging agents HU, MMS, or CPT at concentrations that cause severe lethality in an *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* mutant, both single mutants in either phospho-mutant form did not display damage sensitivity ([Figure 1B](#fig1){ref-type="fig"}). To rule out the possibility of redundancy (*i.e.*, phosphorylation at one site substituting for lack of phosphorylation at the other), we examined every possible double-mutant combination. None of the mutant combinations displayed sensitivity to DNA-damaging agents ([Figure 1C](#fig1){ref-type="fig"}). This indicates that although both sites are known targets for checkpoint kinase ([Mec1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000340)) phosphorylation in response to damage, neither of these sites is important for the DNA-damage response.

*rfa2* "extensive" mutants are viable and display sensitivity to DNA-damaging agents {#s10}
------------------------------------------------------------------------------------

The human RPA2 NT is phosphorylated in response to DNA damage. An amino-acid sequence alignment of the *S. cerevisiae* [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) (NP_014087.1) and the human RPA2 (NP_002937.1) N termini revealed two prominent features ([Figure 2A](#fig2){ref-type="fig"}). First, the budding yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is S/T rich, similar to the human RPA2 NT. Second, although there are no SQ motifs in the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT, the number and position of S/T residues are similar to the human RPA2 NT. Phosphorylation of the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT has been identified only in a *[set1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001161)*Δ mutant during mitosis ([@bib68]) or by the meiosis-specific kinase [Ime2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000003642) at serine 27 during meiosis ([@bib15]). Rad53-dependent phosphorylation of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT in a *[set1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001161)*Δ mutant or deletion of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT (*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*--Δ*40*) suppresses the MMS sensitivity of *[mec3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004279)*Δ cells and results in increased expression of DNA repair genes ([@bib68]). Deletion of the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT also results in shortening of telomeres ([@bib69]). To examine the potential physiological role of the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT in response to DNA damage and outside of the context of a *[set1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001161)*Δ or *[mec3](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004279)*Δ background, we generated yeast *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* phospho-mutant alleles, similar to those used in many human RPA2 studies ([Figure 2B](#fig2){ref-type="fig"}).

![Phenotypic analysis of *rfa2* "extensive" (*rfa2~x~*) mutants. (A) Alignment of RPA2 N-terminal regions (first 38 aa) from *S. cerevisiae* (ScRfa2; NP_014087.1) and *Homo sapiens* (HsRPA2; NP_002937.1). Alignments were performed using T-Coffee (suitable for small alignments) with default settings. Highlighted residues indicate putative phosphorylation sites in *S. cerevisiae Rfa2* and known phosphorylation sites in *H. sapiens* RPA2. (B) Schematic of *rfa2*-extensive mutants used in this study. Designations for domains are as described in [Figure 1A](#fig1){ref-type="fig"}. Serine/threonine amino acid (aa) residues and positions are denoted. Extensive *rfa2* N-terminal mutants (denoted by the subscript *x*) are shown as serine/threonine (S/T) residues mutated to aspartic acids (D) to mimic hyperphosphorylation or to alanines (A) to generate a nonphosphorylatable N-terminus. The extensive deletion (Δ*N*) mutant (denoted by the subscript *x*) removes amino acids 3--37. The *rfa1-t11* allele used is shown above DBD-F in Rfa1, and its amino acid change (lysine → glutamic acid; K45E) is denoted in parentheses. (C) DNA-damage assay of the *rfa2*-extensive mutants. The assay was performed exactly as described in [Figure 1B](#fig1){ref-type="fig"}. Sensitivities to increasing concentrations of phleomycin (PHL) and CPT are shown. Sensitivities to HU and MMS are shown in [Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-2.pdf).](711fig2){#fig2}

Introduction of any [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) N-terminal mutation by plasmid shuffle resulted in the formation of viable cells ([Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-2.pdf)A), as indicated by growth on 5-FOA. To determine if *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* phospho-mutants displayed general growth defects, the growth rate of each mutant was determined. Both the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutant (henceforth, subscript *x* indicates e*x*tensive mutation of all N-terminal serines/threonines; *D* indicates mutation to aspartic acids) and the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* mutant (Δ*N~x~* indicates deletion of N-terminal amino acids 3--37; similar to *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*40* in [@bib68], [@bib69]) display reduced growth when the mutant form is expressed as the only copy of *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* from either from a plasmid ([Table 1](#t1){ref-type="table"}; RMY122-A background) or from its native chromosomal location ([Table 1](#t1){ref-type="table"}; JKM179 background). The reduced growth rate in the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* mutant is consistent with the delayed replication observed for *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*40* ([@bib68]). The *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant (*A~x~* indicates alanines substituted for all N-terminal serines/threonines) grew similarly to wild-type (WT) cells in either background ([Table 1](#t1){ref-type="table"}). This suggests that an [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT that is either lacking or constitutively mimics phosphorylation (*i.e.*, negatively charged) results in a slight-to-modest growth defect, whereas a nonphosphorylatable [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT mutant results in cells that grow as well as WT cells.

###### Growth characteristics of *rfa2~x~* mutants

  *RFA2* allele    Strain background[*^a^*](#t1n1){ref-type="table-fn"}   Growth rate (min/gen)
  ---------------- ------------------------------------------------------ -----------------------
  WT               RMY122-A                                               105.6 ± 11.9
  *rfa1-t11*       RMY122-A                                               161.9 ± 16.6
  *rfa2-D~x~*      RMY122-A                                               112.1 ± 6.0
  *rfa2-A~x~*      RMY122-A                                               102.4 ± 4.7
  *rfa2*-Δ*N~x~*   RMY122-A                                               111.5 ± 6.0
  WT               JKM179                                                 105.6 ± 10.9
  *rfa1-t11*       JKM179                                                 136.1 ± 21.6
  *rfa2-D~x~*      JKM179                                                 131.3 ± 13.9
  *rfa2-A~x~*      JKM179                                                 108.7 ± 13.7
  *rfa2*-Δ*N~x~*   JKM179                                                 144.2 ± 22.1

In the strain RMY122-A, the WT or mutant *rfa2* allele is expressed from its native promoter on a low-copy centromeric vector. In the JKM179 background, the WT or mutant *rfa2* allele was integrated into its normal chromosomal location via two-step gene replacement.

*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* mutants were examined for sensitivity to chemical DNA-damaging agents (*e.g.*, MMS, CPT, HU, or PHL), and although each of these chemicals induces DNA damage through a different mechanism, the results were similar for each treatment. The *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant showed nearly indistinguishable growth compared to WT *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-containing cells on all DNA-damage-inducing media ([Figure 2C](#fig2){ref-type="fig"}, [Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-2.pdf)B)---slight differences were observed only at concentrations of agents that were at least 5- to 25-fold higher than commonly used concentrations. The *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* and *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* mutants were sensitive to all DNA-damaging agents tested ([Figure 2C](#fig2){ref-type="fig"}, [Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-2.pdf)B, [Figure S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-7.pdf)).

DNA-damage sensitivity is observed only when multiple serine/threonine residues in the Rfa2 N-terminus are mutated {#s11}
------------------------------------------------------------------------------------------------------------------

It is clear that *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* extensive N-terminal mutants in which all of the S/T residues are mutated or deleted display damage-sensitive phenotypes. To determine which specific residue(s) might be important for the DNA-damage response, we employed a mutagenesis strategy in which single residues (individual mutants) or clusters of residues were mutated (multimutants). Shuffling-in of any *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~i~* or *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~i~ (subscript i denotes an *i*ndividual amino acid change) mutant plasmids resulted in no discernible growth phenotypes on 5-FOA, indicating that each individual mutant allele was able to complement the chromosomal *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)Δ* with respect to supporting normal cell growth under unstressed conditions ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-6.pdf)A, [Figure S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-3.pdf)A). The ability to tolerate DNA damage was then examined. Although the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutant displayed a damage-sensitive phenotype, *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~i~ mutants were indistinguishable from WT *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* cells with respect to growth on media containing DNA-damaging agents ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-6.pdf)B). In addition, each of the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A*~i~ mutants showed resistance to DNA-damaging agents similar to WT cells ([Figure S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-3.pdf)B), which was not unexpected given the lack of a DNA-damage phenotype for the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant. Taken together, these results indicate that no single putative phosphorylation target site is responsible for the damage sensitivity observed for the extensive *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* mutants.

The above data suggest that if N-terminal residues are physiologically important and potential targets for low-level [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) phosphorylation, there might be a requirement for modification of multiple residues (*i.e.*, a critical mass of phosphorylation) to affect RFA's role in the DNA-damage response. This might also explain why single mutations have little effect, as other potential sites would remain in these mutants. To address this possibility, the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT was divided into three subregions, and clusters of three to four serine/threonine residues were mutated to mimic phosphorylation or to be nonphosphorylatable ([Figure 3A](#fig3){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). These clusters are not only "geographically" partitioned, but also represent corresponding subregions of the human RPA2 NT with respect to order of phosphorylation identified by [@bib3] and [@bib49]. These multimutant alleles were also further combined to generate mutations of six to seven residues within the N-terminal region. All combinations of *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A*~m~ or *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~m~ multimutants supported cell growth in the absence of the original plasmid ([Figure S5](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-9.pdf)), and none of the alanine multimutants demonstrated a damage-sensitive phenotype ([Figure 3B](#fig3){ref-type="fig"}). DNA-damage sensitivity was observed for one aspartic acid multimutant (*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~m1+m3~; [Figure 3C](#fig3){ref-type="fig"}), suggesting that mimicking constitutive phosphorylation of S/T residues in subregions 1 and 3 is responsible for some of the damage sensitivity observed for *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~*.

![Phenotypic analysis of *rfa2* "multi" (*rfa2*~m~) mutants. (A) Schematic depicting *rfa2* multimutants examined and the locations of the amino acid substitutions. Brackets indicate the clusters of serine/threonine (S/T) residues mutated to either aspartic acids, D, or alanines, A. (B) DNA-damage assays for *rfa2-A*~m~ mutants. *rfa2-A*~m~ mutants were recovered by plasmid shuffle ([Figure S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-7.pdf)A) and assayed for sensitivity to DNA damage as described in [Figure 1B](#fig1){ref-type="fig"}. (C) DNA-damage assays for *rfa2-D*~m~ mutants. *rfa2-D*~m~ mutants ([Figure S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.114.173211/-/DC1/genetics.114.173211-7.pdf)B) that could be recovered by plasmid shuffle were assayed for DNA-damage sensitivity as described in [Figure 1B](#fig1){ref-type="fig"}. *rfa2-D*~m1~ (not shown) was recovered and did not display a damage phenotype.](711fig3){#fig3}

###### Rfa2 N-terminal regions, multimutant alleles examined, serine/threonine residues mutated, and their putative analogous residues in human RPA2

  Rfa2 N-terminal region   Allele[*^a^*](#t2n1){ref-type="table-fn"}   Rfa2 residues changed/removed   Putative analogous human RPA2 residues
  ------------------------ ------------------------------------------- ------------------------------- ----------------------------------------
  1 (aa 3--14)             *rfa2-D*~m1~, *A*~m1~, or Δ*N*~1~           T3, S11--12, T14                S4, S8, S11--13
  2 (aa 21--27)            *rfa2-D*~m2~, *A*~m2~, or Δ*N*~2~           S21, S23, S27                   T21, S23, S29
  3 (aa 30--40)            *rfa2-D*~m3~, *A*~m3~, or Δ*N*~3~           S30, T32, T34                   S33

Multimutant allelic forms were also combined to form multimutants in which 6-7 serine/threonine (S/T) residues were mutated (*e.g.*, *rfa2-D~m1+m2~* designates a form where both regions 1 and 2 were mutated to aspartic acids (D)).

Genetic interactions with another RPA subunit mutant or with a DSB repair mutant reveal differences in *rfa2* damage-sensitive mutants {#s12}
--------------------------------------------------------------------------------------------------------------------------------------

Synthetic genetic interactions and epistasis studies are useful for identifying factors that act in the same pathway and/or the same complex. To identify the importance of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT in a complex or pathway, we assayed for synthetic genetic interactions between *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* N-terminal mutants and either *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* or *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ, both of which individually lead to DNA-damage-sensitive phenotypes. [Mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837) is a subunit of the yeast MRX complex (MRN in human cells) necessary for DSB repair and checkpoint function ([@bib83]; [@bib39]; [@bib66]). Synthetic genetic interaction between *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* N-terminal alleles and *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ was examined, because human RPA2 and Mre11 physically interact with one another, and this interaction appears to be regulated by the N-terminal state of human RPA2 and the N-terminus of RPA1 ([@bib58]). Synthetic genetic interaction with the *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* allele was examined, because it lies in a gene that encodes a different subunit within the same complex as [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256).

Genetic interactions between *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* and *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* extensive mutants were examined by plasmid shuffle. Both the *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* and *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* double mutants were viable. However, the *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* double mutant displayed synthetically lethality, as only a few 5-FOA-resistant microcolonies were observed for this mutant ([Figure 4B](#fig4){ref-type="fig"}), which were unable to be propagated any further. Thus, although both *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* and *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* single mutants display damage-sensitive phenotypes, they display differential genetic interactions with *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11*.

![Genetic interactions with *rfa1-t11*. (A) Schematic of rfa2 subregion deletion mutants examined. (B) Spot assay measuring genetic interaction between *rfa2* mutants and *rfa1-t11* by plasmid shuffle. RMY122-A strains containing pJM132 were cotransformed with plasmids containing either *RFA1* or *rfa1-t11* and *rfa2* mutant alleles. Transformants were selected for on SD--His--Leu--Ura plates and "shuffling out" of pJM132 (*i.e.*, the ability of a particular mutant to support viability) was detected as growth on 5-FOA. (C) Examining which subregion of the Rfa2 N-terminus is responsible for the DNA-damage phenotypes of *rfa2*-Δ*N~x~* strains. Damage assays for *rfa2*-Δ*N*~1~, *rfa2*-Δ*N*~2~, or *rfa2*-Δ*N*~3~ strains were performed as described in [Figure 1B](#fig1){ref-type="fig"}. (D) Examining genetic interactions between *rfa2*-Δ*N* subregion mutants and *rfa1-t11*. Since *rfa2*-Δ*N~x~* displays damage sensitivities and synthetic lethality with *rfa1-t11*, we examined *rfa2*-Δ*N~1~*, *rfa2*-Δ*N~2~*, or *rfa2*-Δ*N~3~* subregion mutants in combination with *rfa1-t11*. Cells were examined as in [Figure 4B](#fig4){ref-type="fig"}. (E) Growth assay of *rfa1-t11 rfa2*-Δ*N* subregion double mutants recovered from plasmid shuffle. Cells were grown overnight, sonicated, counted, diluted to 2.4 × 10^5^ cells/ml, and serial diluted as threefold dilutions. The serial dilutions were spotted and examined as described in [Figure 1B](#fig1){ref-type="fig"} (damage assays are not shown, as *rfa1-t11* cells have a severe sensitivity that appears to be epistatic to any *rfa2* extensive mutant form).](711fig4){#fig4}

Partial deletions of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT were constructed to identify which mutated subregion(s) was responsible for the DNA-damage-sensitive and/or *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* synthetic lethal phenotypes. Similar to the multimutants, we divided the putative phosphorylation sites into three clusters (subregions) and deleted each subregion ([Figure 4A](#fig4){ref-type="fig"}). Deletion of any cluster of putative sites did not affect the ability to shuffle out the WT *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* plasmid ([Figure 4B](#fig4){ref-type="fig"}); however, DNA-damage assays revealed that *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N*~3~ displayed a moderate damage-sensitive phenotype, indicating that this subregion (or perhaps this cluster of S/T residues) is important in the damage response ([Figure 4C](#fig4){ref-type="fig"}). Double mutants of these partial deletion alleles and *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* revealed that all of the double mutants are viable, although both *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~1~* and *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~3~* display synthetic sickness, as indicated by less efficient loss of the WT *[RFA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-containing plasmid ([Figure 4D](#fig4){ref-type="fig"}) and by reduced growth of the recovered mutant on YPD under unstressed conditions ([Figure 4E](#fig4){ref-type="fig"}). Damage-sensitivity effects could not be determined in mutants containing *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11*, as this mutation already leads to very severe damage-dependent phenotypes. It is of interest to note that *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~1~* and *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~3~* remove the same subregions that, when mutated to aspartic acids in the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~m1+m3~ mutant lead to a damage-sensitive phenotype (see results above and [Figure 3C](#fig3){ref-type="fig"}), suggesting that these subregions of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT are important for [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) function.

Although RPA and [Mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837) physically interact, it has been previously demonstrated that yeast *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-DAmP* (*d*ecreased *a*bundance of *m*RNA *p*erturbation) *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ or *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-DAmP [mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ double mutants display a synthetic lethality phenotype ([@bib17]), suggesting that yeast RFA and [Mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837) have synergistic, yet independent, functions. It was possible that if the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT were important for function in the DNA-damage response, that mutation of this domain alone might account for this synthetic genetic interaction observed previously. Each of the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* N-terminal extensive mutants or *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* was introduced into an isogenic *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ strain, and viability was assessed via the plasmid shuffle assay. Three interesting results were observed. First, the *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ double mutant was synthetically lethal under unstressed conditions ([Figure 5A](#fig5){ref-type="fig"}). It was known previously that a human RPA1-t11 mutation disrupts interaction with [Mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837) ([@bib58]); however, it is clear that the synthetic lethality observed for the *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ double mutant in yeast is not due to lack of interaction (*i.e.*, any interaction would already be disrupted by virtue of the absence of [Mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)). The data are consistent with a role for RFA independent from its interaction with [Mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837). Second, the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ double mutant is synthetically lethal ([Figure 5A](#fig5){ref-type="fig"}), similar to that of an *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ double mutant. This would suggest that *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* and *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* mutants might have a fundamentally similar defect in function. Third, the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ double mutant is viable ([Figure 5A](#fig5){ref-type="fig"}), unlike the *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ or *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ double mutants. This would again suggest that the defect in function in *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* cells is different from that of *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* or *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11*.

![Genetic interactions with *mre11*Δ. (A) Replica plating to measure genetic interaction between *rfa1* or *rfa2* mutants and *mre11*Δ by plasmid shuffle. RMY122-A--*mre11*Δ strains containing pJM132 were cotransformed with plasmids containing various allele combinations of *RFA1* and *RFA2*. Transformants were selected for on SD--His--Leu--Ura plates and picked to a SD--His--Leu--Ura master plate (four independent colonies for each shuffle). "Shuffling out" of pJM132 was examined by replica plating the master plate onto SD-Com (synthetic complete with amino acids supplemented) and 5-FOA plates, and the plates were incubated at 30° for 2--4 days. Growth on 5-FOA indicates that the combination of mutant *RFA1* and/or *RFA2* alleles supports cell viability. (B) Examining which aspartic acid mutations in the Rfa2 N-terminus are responsible for the phenotype of rfa2-*D~x~* strains. Since rfa2-*D~x~* displays damage sensitivities and synthetic lethality with mre11Δ, we examined rfa2-*D*~m~ mutations (where the multimutant form is indicated by the subregion of the Rfa2 N-terminus as shown in [Figure 3A](#fig3){ref-type="fig"}) in combination with mre11Δ. Cells were examined as in [Figure 4B](#fig4){ref-type="fig"}. (C) Spotting of serial dilutions of *rfa2-D*~m~ *mre11*Δ cells recovered by plasmid shuffle. Cells were grown overnight, sonicated, counted, diluted to 2.4 × 10^5^ cells/ml, and serial diluted as threefold dilutions. Five microliters of each dilution were spotted onto YPD (damage assays are not shown, as *mre11*Δ cells have a severe sensitivity that appears to be epistatic to any *rfa2* extensive mutant form).](711fig5){#fig5}

Since *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* showed a genetic interaction with *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ, *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* multimutants were utilized in an attempt to identify the subregion(s) contributing to the synthetic lethality observed in [Figure 5A](#fig5){ref-type="fig"}. *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~m~ double-mutant combinations were generated and assessed for viability. Interestingly, *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~m1+m3~ was synthetically lethal, similar to the *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutant ([Figure 5B](#fig5){ref-type="fig"}). This suggests that S21, S23, and S27 do not contribute to the genetic interaction observed for the *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutant. This is also consistent with the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~m1+m3~ mutant displaying the most severe damage-sensitive phenotype ([Figure 3C](#fig3){ref-type="fig"}). Finally, the double mutants *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~m2+m3~ and *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D*~m3~ show similar synthetic sickness ([Figure 5, B and C](#fig5){ref-type="fig"}). Both of these double mutants have subregion 3 mutated to aspartic acids, identifying this subregion as contributing to synthetic sickness (*i.e.*, slow growth or inviability) in an *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ strain, when in a constitutively phosphomimetic state.

Protein phosphorylation and checkpoint initiation occurs in *rfa2* N-terminal mutants in response to DNA damage {#s13}
---------------------------------------------------------------------------------------------------------------

While [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) is phosphorylated on S122 by [Mec1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000340) in response to DNA damage ([@bib11]; [@bib53]; [@bib7]), it has not been directly demonstrated that phosphorylation occurs in mitotically damaged cells in the N-terminal region of yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) (in a *[SET1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000001161)* strain). This is in stark contrast to human RPA2, where upon DNA damage, the N-terminus is hyperphosphorylated on multiple residues by ATR, ATM, and DNA-PK, displaying obvious shifts in mobility by SDS--PAGE ([@bib49]). To determine whether the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is also phosphorylated in response to DNA damage, we examined asynchronous exponentially growing cells that were either unstressed or treated with MMS, leading to replicative stress and DNA breaks. In gels containing 50 μM Phos-Tag ([@bib41]), a distinct phosphospecies was observed for all *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-extensive mutants in both exponentially growing and damaged cells ([Figure 6A](#fig6){ref-type="fig"}), similar to that observed previously ([@bib68]). The most important feature to note is that the shifted [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) phosphospecies was present in all *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-extensive mutant cells examined, including the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant lacking all S/T residues in the N-terminus, indicating that the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is not a predominant target for phosphorylation.

![Phosphorylation phenotypes of *rfa2* extensive mutants. (A) Phosphorylation of Rfa2 before and after DNA damage. Cells were grown to ∼1 × 10^7^ cells/ml, split into two cultures, and one of the cultures was treated with 0.03% MMS for 3 hr. Following treatment, ∼2 × 10^7^ cells were collected and lysed, and one-tenth of each protein extract (equivalent to ∼2 × 10^6^ cells) was resolved in 8% polyacrylamide (29:1 mono:bis) gel in the absence or presence of Phos-Tag (PT; micromolar is indicated to left of each blot) in the gel. *RFA1* and *RFA2* alleles present and type of damage treatment is denoted above each blot. Following transfer, Rfa2 protein species were detected with rabbit polyclonal antibody to Rfa2. Dash, unphosphorylated species; arrowhead, phosphorylated/slower mobility species. Rightmost symbols represent Rfa2 species from the *rfa2*-Δ*N~x~* strain. In gels where no Phos-Tag was added, phosphorylated/changed species were difficult to resolve. Also, note two diffuse shifted Rfa2 species from the *rfa2-D~x~* strain, consistent with the shift observed for 25 mM PT. (B) Detection of Rad53 and Rfa1 proteins and post-translational modifications. For Rad53, one-tenth of the protein extract was separated in a 6% polyacrylamide (37.5:1 mono:bis) gel. For Rfa1, one-twentieth of each protein extract (equivalent to ∼1 × 10^6^ cells) was resolved in a 6% polyacrylamide (29:1 mono:bis) gel in the absence or presence of Phos-Tag in the gel. Proteins were detected with rabbit polyclonal antibodies to Rad53 and Rfa1, respectively. Designations are as in [Figure 6A](#fig6){ref-type="fig"}.](711fig6){#fig6}

Interestingly, we were able to observe a distinct phosphospecies using 25 μM Phos-Tag technology for the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* and *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* mutants. This [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) species was also observed in a 50 μM Phos-Tag gel as a more diffuse and slightly higher-shifted species identified from *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutant cells following DNA damage, consistent with the 25 μM Phos-Tag result. This species was not present in WT, *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11*, or *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* cells. It is worth noting that this phosphospecies was observed only in *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-extensive mutants that are DNA-damage sensitive, and the species was DNA-damage specific ([Figure 6A](#fig6){ref-type="fig"}). It has not been determined if this phosphospecies is the same in *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* and *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* cells, nor if this phosphorylation is causative of or simply correlative with DNA-damage sensitivity. Post-translational modification of [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) is unaffected in all of the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-extensive mutant cells both before and after DNA damage ([Figure 6B](#fig6){ref-type="fig"}). Although the intensity of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) protein signal in *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* cells was consistently reduced, it was unclear if this is due to instability of [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) protein, epitope masking, or a reduction in available epitope due to the missing N-terminus. Consistent with the latter possibilities, the level of [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) protein detected is similar in all mutants ([Figure 6B](#fig6){ref-type="fig"}). Since human RPA1 stability is dependent on RPA2 ([@bib33]), one would predict that if yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) were reduced, a similar reduction in [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) might also occur. However, this was not observed.

One mechanism by which a mutant could display DNA-damage sensitivity is through the inability to activate, maintain, or recover properly from a checkpoint. Since human RPA2 is phosphorylated by checkpoint kinases in response to DNA damage, we surmised that the damage sensitivity observed in *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* mutant yeast strains might be due to misregulation of checkpoint function. We examined G2/M checkpoint activation in *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* mutants by measuring the phosphorylation of yeast [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) (homolog of human Chk2). [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) lies downstream of yeast RFA in the checkpoint pathway and becomes phosphorylated (activated) in response to DNA damage ([@bib45]; [@bib61]; [@bib34]; [@bib9]). [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) is phosphorylated not only in WT cells, but also in all of the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-extensive mutants when cells are treated with MMS ([Figure 6B](#fig6){ref-type="fig"}) or when a single DSB is induced ([Figure 7B](#fig7){ref-type="fig"}). This indicates that the modification or loss of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT has no observable effect on [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) activation and suggests that checkpoint establishment after DNA stress is unaffected.

![Checkpoint adaptation phenotypes of *rfa2* extensive mutants. (A) Adaptation phenotypes in *rfa2-D~x~* and *rfa2-A~x~* mutant cells at 0, 8, and 24 hr after HO break induction. Microdissection was used to identify and separate early S-phase cells onto SG-Com plates, which led to expression of HO endonuclease. After 0, 8, and 24 hr, cells were examined microscopically and quantitated for number of cells observed for each colony. (B) Quantitation and microscopic representation of adaptation after 24-hr post-HO break induction. Microscopic representation (top), and multiple independent experiments (*N* \> 8 for all strains) were quantitated (bottom) to determine the percentage of colonies with \>2 cells. (C) Rad53 phosphorylation in *rfa2*-extensive mutants. Expression of HO endonuclease was induced in exponentially growing cells by the addition of 2% galactose to the media. Cells were collected at various time points following galactose addition, and 40 μg of whole-cell extracts were probed with anti-Rad53 antibody. Slower migrating species indicate phosphorylated Rad53 (as described in [@bib62]). (D) The effect of *rfa2*-extensive mutations on Rad53 phosphorylation state in yku70Δ strains. Phosphorylation of Rad53 was examined as described in [Figure 7C](#fig7){ref-type="fig"}. *yku70*Δ and *yku70*Δ *rfa1-t11* were previously examined in [@bib62] and are controls for Rad53 phosphorylation in adaptation-deficient and adaptation-proficient strains, respectively.](711fig7){#fig7}

Checkpoint adaptation in *rfa2*-extensive mutant strains {#s14}
--------------------------------------------------------

Checkpoint adaptation is the ability of a cell to override G2/M checkpoint arrest and proceed through the cell cycle even in the presence of unrepaired DNA damage, and it has been suggested that this is a mechanism by which cells might survive, even when damage persists ([@bib28]). The initial phosphorylation of [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) is necessary to establish a checkpoint in yeast, and it should be noted that *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* cells have initial [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) phosphorylation that is indistinguishable from WT cells in response to DNA damage ([@bib45]; [Figure 6B](#fig6){ref-type="fig"}). However, *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* promotes adaptation in normally adaptation-deficient *[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ or *[tid1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000277)*Δ mutants that is mediated through a reduction in phosphorylation of [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) ([@bib44]; [@bib62]).

We have demonstrated in this study that *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* and *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutants both displayed damage sensitivity, and each displayed synthetic lethality when combined with *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ. We addressed whether *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* N-terminal mutants affect adaptation. In the presence of a single, irreparable DSB at the *MAT* locus, *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* or *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant cells are capable of arresting at the G2/M checkpoint by 8 hr similar to WT cells, as indicated microscopically as a cell with a single large bud ([Figure 7A](#fig7){ref-type="fig"}) and by phosphorylation (activation) of [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) ([Figure 7C](#fig7){ref-type="fig"}). However, only *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* cells display an adaptation frequency that is nearly indistinguishable from WT or *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* cells ([Figure 7B](#fig7){ref-type="fig"}). Furthermore, when *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* was combined with *[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ (normally adaptation deficient), the cells now showed adaptation proficiency, similar to that reported previously for *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11 [yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ cells ([@bib44]; [Figure 7, A and B](#fig7){ref-type="fig"}). This is corroborated by the observation that the majority of [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) is not phosphorylated by 18 hr after induction of a DSB ([Figure 7D](#fig7){ref-type="fig"}) in these cells.

Interestingly, *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* cells display reduced adaptation ([Figure 7, A and B](#fig7){ref-type="fig"}) and a slightly later reduction in phosphorylation of [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) after DNA damage ([Figure 7C](#fig7){ref-type="fig"}). Furthermore, the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ mutant is adaptation deficient, similar to the *[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ single mutant ([Figure 7B](#fig7){ref-type="fig"}). Supporting *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ adaptation deficiency is the inability of [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) to be dephosphorylated, even 18 hr after damage induction ([Figure 7D](#fig7){ref-type="fig"}).

Discussion {#s15}
==========

The N-terminal region of Rfa2 is important for proper cellular response to DNA damage {#s16}
-------------------------------------------------------------------------------------

The results presented in this work demonstrate that the N-terminus of yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) is required for a proper DNA-damage response. This is indicated by the fact that removal of this domain (*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~*) leads to DNA-damage-sensitive phenotypes. However, phosphorylation of the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is not necessary for cells to respond to repairable DNA damage, since cells bearing a nonphosphorylatable form of this domain (*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~*) exhibit near wild-type growth and DNA-damage-tolerance phenotypes.

Using Western blotting and Phos-Tag technology, we were unable to detect major differences in yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) phosphorylation in the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* NT mutants, except for an additional phosphospecies in the damage-sensitive *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* mutants only. The additional modification observed must reside outside of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT, as it is observed in the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* mutant. This indicates that the *Saccharomyces* [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is not the predominant region for damage-induced phosphorylation, but that the state of this domain can influence the damage response and/or additional modification of [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) outside of the N-terminus. The lack of readily detectable damage-specific phosphorylation in the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is in stark contrast to the human RPA2 NT, but is completely consistent with the observation that *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant yeast cells are resistant to DNA damage.

It is worth noting that even in N-terminal mutants where DNA-damage sensitivity was observed, post-translational modification of [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) did not appear to be affected. Despite the apparent lack of major phosphorylation in the WT [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT, we note that when individual residues on RFA ([Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)--S178 and [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--S122) previously identified to be phosphorylated by [Mec1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000340) are mutated to nonphosphorylatable forms (or phosphomimetic forms), there was no observable DNA-damage-sensitive phenotype. This indicates that [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)--S178 and [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--S122 are neither redundant nor important for the damage response or that any mutant phenotype is so subtle that it cannot be detected by the assays performed in this study. As our study was done in haploid strains growing mitotically, this does not preclude the importance of post-translational modification of these residues in meiosis, where a phenotype has been observed for [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)--S122 mutants ([@bib7]). It is clear that the phenotypes observed for N-terminal mutants of yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) are far more severe than those for known phosphorylation target-site mutants, suggesting that similar to human RPA2, the N-terminal region is more important for the DNA-damage response.

Subregions 1 and 3 are responsible for phenotypes observed in Rfa2 N-terminal mutants {#s17}
-------------------------------------------------------------------------------------

All *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* individual site mutants showed robust growth and resistance to DNA damage, suggesting that perturbing one site in the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is not enough to elicit a phenotype. Although we could not detect an obvious lack of phosphorylation in any of the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-extensive mutants in response to DNA damage, we did observe that certain regions of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT were more sensitive to alteration than others. Dividing the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT into three subregions revealed that all of the growth defects, DNA-damage defects, and genetic interactions we observed could be attributed to mutation of subregion 1 (aa 3--14) and/or subregion 3 (aa 30--40) of the N-terminus ([Table 3](#t3){ref-type="table"}). It is interesting to note that subregions 1 and 3 are analogous to subregions of human RPA2 ([Table 3](#t3){ref-type="table"}) that contain all but one (T21) of the primary DNA-damage-specific targets of checkpoint kinases ([@bib3]; [@bib49]). If low-level (currently undetectable) post-translational modification is occurring in the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT, we would suggest that it is potentially occurring in both of these subregions. Alternatively, these subregions are important and may have evolved in higher eukaryotes to be post-translationally modified during DNA damage for reasons that are not yet clear.

###### Qualitative summary of *rfa2* N-terminal mutant phenotypes and genetic interactions

                                    Genetic interaction[*^a^*](#t3n1){ref-type="table-fn"}   Adaptation[*^a^*](#t3n1){ref-type="table-fn"}                
  ----------------- ------- ------- -------------------------------------------------------- ----------------------------------------------- ------------ ------------
  WT                +++++   +++++   NA                                                       NA                                              Proficient   Deficient
  *rfa1-t11*        \+      0       NA                                                       Lethality                                       Proficient   Proficient
  *rfa2-D~x~*       +++     ++      None                                                     Lethality                                       Proficient   Proficient
  *rfa2-A~x~*       +++++   +++++   None                                                     None                                            Reduced      Deficient
  *rfa2*-Δ*N~x~*    +++     ++      Lethality                                                None                                            ND           ND
  *rfa2-D*~m1+m3~   +++++   +++     ND                                                       Lethality                                       ND           ND
  *rfa2*-Δ*N~1~*    +++++   ++++    Sickness                                                 ND                                              ND           ND
  *rfa2*-Δ*N~3~*    +++++   ++      Sickness                                                 ND                                              ND           ND
  *rfa2-D*~m2+m3~   +++++   ++      ND                                                       Sickness                                        ND           ND
  *rfa2-D*~m3~      +++++   +++++   ND                                                       Sickness                                        ND           ND

NA, not available/applicable; ND, not determined.

Scale is +++++, best growth/most damage resistant; +++, moderate growth/moderately damage resistant; +, slow growth/slightly damage resistant; 0, no growth/not damage resistant.

Genetic interactions suggest overlapping, yet different functions for the yeast Rfa1 and Rfa2 N termini {#s18}
-------------------------------------------------------------------------------------------------------

Phosphorylation (or phosphomimetic mutations) of the human RPA2 NT can have an effect in regulating protein interactions and/or DNA interactions that involve the N-terminus of RPA1 (DBD-F). Evidence that a phosphomimetic RPA2 N-terminal peptide affects the NMR structure of purified RPA1 DBD-F in a fashion similar to that of ssDNA binding to RPA1 DBD-F suggests that this peptide competes with ssDNA for binding to DBD-F ([@bib8]). Furthermore, it has been demonstrated that DBD-F is important for interaction of human RPA1 with human Mre11, and mutation of this domain (RPA1-t11) or a phosphomimetic form of human RPA2 (RPA2-*D~x~*) disrupts this interaction ([@bib58]).

Based on this idea, one might conjecture that a yeast *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutant would behave similarly to an *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* mutant. In this regard, both mutants grew more slowly, displayed damage sensitivities, were synthetically lethal in combination with *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ, and exhibited the ability to promote adaptation in a *[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ background. This is consistent with a model in which a phosphorylated RPA2 N-terminus affects the function of the RPA1 N-terminus (DBD-F), similar to if DBD-F were mutated. It has not been determined whether a phosphomimetic human RPA2 affects the NMR structure of an RPA1-t11 (DBD-F) mutant. However, our results are consistent with this model in which hyperphosphorylated yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) interacts with DBD-F of yeast [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) to potentially disrupt protein/DNA interactions.

Despite both being DNA-damage sensitive, it is clear that the defect(s) in *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutants differs from the defect(s) in *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* mutants. The *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* mutant is intriguing, because it does not behave like an *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant, even though neither of these [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) proteins is phosphorylatable on their N-terminus. This clearly delineates between a requirement for the presence of the domain *vs.* a requirement for phosphorylation of the domain. Perhaps more intriguing is the fact that the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~* mutant does not display a genetic interaction with *[mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837)*Δ, but does display a genetic interaction with *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11*. This suggests that removal of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT results in a cellular defect similar to when [Mre11](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004837) is deleted. Furthermore, deletion of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT confers a defect distinct from that observed in *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* mutant cells that lack a functional DBD-F. It has been proposed that the human RPA2 N-terminus may function by regulating the function of the human RPA1 N-terminus ([@bib8]; [@bib58]). These studies indicate that the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) N-terminus has a role beyond regulating the [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) N-terminus, and it will be important to determine what that role(s) is.

Transition from a "normal" damage response to adaptation may depend on the Rfa2 N-terminus {#s19}
------------------------------------------------------------------------------------------

In this study, a nonphosphorylatable N-terminal form of [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) functions nearly indistinguishably from WT [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) after DNA damage. Perhaps more importantly, the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutant is damage sensitive. Therefore, it is curious that in response to DNA damage, human RPA2 is hyperphosphorylated on its N-terminus. Differences between yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) and human RPA2 might simply be caused by cellular complexity (*e.g.*, human RPA interacts with proteins not found in yeast cells and might require additional modification to regulate these interactions). Alternatively, differences could be due to the experimental parameters of studies performed in human tissue culture *vs.* yeast. Whatever the case, it is clear that lack of phosphorylation in the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT is tolerated quite well under commonly used DNA-damage assay conditions in yeast.

What if the DNA lesion was such that it was either difficult to repair or, perhaps, irreparable? A feature shared between a cell that is permanently arrested *vs.* a cell that is inviable is that neither is "growing." Checkpoint adaptation allows for the possibility of cell growth, with the potential for the lesion to be repaired later. Although genome stability appears to be compromised \[*i.e.*, increased spontaneous chromosome loss and break-induced repair (BIR)\] in adaptation-proficient mutants, it has also been demonstrated that adaptation results in cells with higher resistance upon exposure to DNA-damaging agents (*e.g.*, X irradiation) in diploid cells ([@bib28]). It is clear that all of the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-extensive mutants display initial phosphorylation of [Rad53](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000006074) indistinguishable from WT cells following MMS treatment or 8 hr after an HO-induced DSB. This would suggest that a G2/M checkpoint establishment defect is not the explanation for the damage sensitivity observed for some *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* N-terminal mutants. However, we have observed that the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* mutant promotes adaptation when combined with *[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ, similar to that observed for *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11*. There is a precedent for checkpoint release in human cells, as it has been demonstrated that [RPA2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) N-terminal phosphorylation is necessary to exit M phase and enter G1 phase in the presence of mitotic DNA damage ([@bib4]). We propose that the DNA-damage sensitivity observed for *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-D~x~* strains may indeed be due to the ability to promote premature adaptation, resulting in mitotic division despite the persistence of damaged DNA. If cells "adapt" during continued/prolonged treatment with genotoxic agents (*i.e.*, spot assays on plates containing DNA-damaging agents), the lack of arrest and coupled increase in genomic instability would presumably lead to additional DNA damage and/or chromosomal loss. Although tolerated in diploid cells ([@bib28]), this would be quite detrimental to the haploid cells in our studies and would manifest as reduced colony growth in a damage assay. Our data corroborate the idea that adaptation is beneficial to the cell only when it has a diploid genome content to compensate for chromosomal loss or rearrangement.

It is worth noting that *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutants were indistinguishable from WT cells in almost every assay, except for adaptation. In fact, the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* mutant displayed an adaptation-reduced phenotype and became fully adaptation proficient only when combined with an *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* mutation. This suggests that the lack of serine/threonine residues and/or an inability to post-translationally modify these residues in the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT inhibits adaptation in otherwise WT cells (and especially in *[yku70](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000004897)*Δ cells). Because these cells prolong resistance to progression into M phase until DNA damage has been repaired, this is a plausible explanation for why they do not display DNA-damage sensitivities using common DNA stressors. Despite being adaptation-deficient, *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* cells grow indistinguishably from WT cells in the absence of stress, indicating that the inability to enter M phase is reduced only in the presence of unrepaired DNA and not under unstressed conditions.

We propose a model ([Figure 8](#fig8){ref-type="fig"}) in which the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT plays a role in determining whether cells adapt. In this model, we propose that prolonged checkpoint arrest will lead to adaptation through "inactivation" of the yeast [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) N-terminus (DBD-F; similar to that of the *[rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065)-t11* mutation) or modification of the yeast [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) N-terminus ([Figure 8](#fig8){ref-type="fig"}, right side). Alternatively, an inability to disrupt [Rfa1](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000000065) DBD-F function or lack of modification of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT in the presence of DNA damage helps to reinforce (*i.e.*, maintain) the checkpoint until the damage is repaired, promoting proper checkpoint recovery ([Figure 8](#fig8){ref-type="fig"}, left side). Consistent with this, a nonphosphorylatable *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* NT mutant displays reduced adaptation. In cases where damage is repairable and adaptation would not be necessary, the *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)* mutants that are nonphosphorylatable (*[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)-A~x~* and *[rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256)*-Δ*N~x~*) display very different phenotypes, indicating that there is a difference between having a domain that cannot be phosphorylated on serine/threonine residues and not having the domain at all, as long as the damage is repairable and does not persist.

![Model for Rfa2 N-terminus function in checkpoint maintenance and adaptation. In response to DNA damage, cells undergo recognition of the lesion and signaling to halt the cell cycle by establishing the G2/M checkpoint. The initiation of the checkpoint response occurs, regardless of the state of the N-terminus of either Rfa1 or Rfa2 (denoted as gray boxes to indicate each is either inactive or not present). The decision to override the checkpoint is affected by the state of the Rfa1 and/or Rfa2 N termini. Cells with a functional Rfa1 DBD-F (denoted by a green box) or Rfa2 where the N-terminus is present and in a nonphosphorylated state (denoted by a blue box) appear to less readily adapt, suggesting a propensity to maintain checkpoint function until repair is complete followed by proper checkpoint recovery. If damage persists, the N-terminus of Rfa1 may be inactivated (denoted by a gray box with red slashed circles) and/or the Rfa2 N-terminus may become phosphorylated (denoted by multiple red circles). The Rfa2 N-terminus may not be phosphorylated or may be dephosphorylated when normal ("repairable") DNA damage is present; however, upon persistent ("irreparable") damage, modification of the Rfa2 N-terminus may occur to promote entry into M-phase as a "last-ditch effort" for cell survival.](711fig8){#fig8}

It is important to address the physiological importance of hyperphosphorylation of RPA2 in response to DNA damage in human (and potentially many higher eukaryotic) cells. It is also important to understand how yeast accomplish proper DNA repair and cell-cycle regulation without obvious post-translational modification of the [Rfa2](http://www.yeastgenome.org/cgi-bin/locus.fpl?dbid=S000005256) NT. Why this domain is necessary in yeast, but post-translational modification is not, will be of importance in identifying the mechanism(s) of RFA function, not only in yeast, but perhaps in other eukaryotic organisms where phosphorylation of the RPA2 N-terminus is not necessary or does not occur in response to DNA damage.
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